Results 61 to 70 of about 13,981 (252)

Novel and recurrent histopathologic patterns of mogamulizumab‐associated rash: diagnostic implications and insights for accurate diagnosis

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Mogamulizumab‐associated rash (MAR) is a frequent side‐effect of a treatment with Mogamulizumab that poses diagnostic challenges. Patients and methods We reviewed our database for novel histological patterns in MAR. Results Four new histological patterns were identified: (1) A pagetoid pattern, which could be mistaken for CD8 ...
Christina Mitteldorf
wiley   +1 more source

Reações cutâneas graves adversas a drogas: aspectos relevantes ao diagnóstico e ao tratamento - Parte II Severe cutaneous adverse drug reactions: relevant aspects to diagnosis and treatment - Part II

open access: yesAnais Brasileiros de Dermatologia, 2004
As reações cutâneas graves adversas à droga são as que geralmente necessitam de internação hospitalar, por vezes em unidade de terapia intensiva ou de queimados, com observação minuciosa dos sinais vitais e da função de órgãos internos.
Paulo Ricardo Criado   +4 more
doaj   +1 more source

Vaccination in dermatology 2025: Update considering current recommendations of the German Standing Committee on Vaccination

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The immunosuppressive and immunomodulatory treatment of dermatological patients necessitates the regular review and updating of standard vaccinations and vaccines indicated for specific conditions. The German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute regularly publishes evidence‐based vaccination recommendations ...
Johanna Stoevesandt   +3 more
wiley   +1 more source

Amoxicillin Morbilliform Drug Eruption in Pediatric Male with Poor Feeding Treated with Cyproheptadine: A Case Report

open access: yesInternational Journal of Medical Students, 2018
Background: Cyproheptadine (CY) is an antihistaminic agent that is commonly used for symptom relief in skin conditions. The most common pattern of cutaneous drug eruption in children is the exanthematous type, with the penicillin family often cited.
Daniel Nguyen, Christina Vo
doaj   +1 more source

A case of hemophagocytic lymphohistiocytosis caused by an Epstein-Barr virus infection, presenting with unremitting fever and rash [PDF]

open access: yesPediatric Emergency Medicine Journal, 2019
Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome caused by excessive activation of lymphocytes and macrophages, leading to cytokine storm.
Seong-Beom Oh, Chan-Young Koh
doaj   +1 more source

Unilateral Laterothoracic Exanthema [PDF]

open access: yesThe Journal of Pediatrics, 2021
Israel Pérez-López   +2 more
openaire   +3 more sources

The price of tumor control [PDF]

open access: yes, 2013
Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces adverse events (AE) in up to 64% of patients.
Bergmann, Tanja   +35 more
core   +1 more source

Equine coital exanthema in a stallion [PDF]

open access: yesArquivo Brasileiro de Medicina Veterinária e Zootecnia, 2010
Em agosto de 2008, um garanhão da raça Mangalarga Marchador, de quatro anos de idade, com histórico clínico de apatia, inapetência e edema de prepúcio e escroto, apresentou, ao exame clínico, exsudato purulento fluindo pelo óstio prepucial, prepúcio e mucosa peniana com inúmeras lesões circulares de bordos elevados e hiperêmicos, centro ulcerado ...
Ferreira, C.   +9 more
openaire   +4 more sources

Acute transverse myelitis and psoriasiform dermatitis associated with Sjoegren’s syndrome: a case report [PDF]

open access: yes, 2014
BACKGROUND: Clinical complications of Sjoegren’s syndrome include myelitis and skin manifestations. There is scarce observational data and a lack of randomised controlled studies regarding the treatment of Sjoegren’s syndrome in the presence of such ...
Benedikt J Schwaiger   +6 more
core   +3 more sources

Dupilumab for the Treatment of Cutaneous Immune‐Related Adverse Events: A Systematic Review

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT The emergence of immune checkpoint inhibitors has revolutionized the landscape of cancer treatment in the modern era. However, cutaneous immune‐related adverse events (cirAEs) are common, significantly affecting patients' quality of life and often leading to treatment discontinuation, which may compromise oncological outcomes.
Ioannis‐Alexios Koumprentziotis   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy